Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

ClinicalTrials.gov ID: NCT05735743

Public ClinicalTrials.gov record NCT05735743. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 14, 2026, 1:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

MoVE Trial: Motivational Strategies To Empower African Americans To Improve Dialysis Adherence

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

Study identification

NCT ID
NCT05735743
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Enrollment
176 participants

Conditions and interventions

Interventions

Behavioral

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 8, 2023
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027
Last update posted
Apr 22, 2026

2023 – 2027

United States locations

U.S. sites
6
U.S. states
2
U.S. cities
3
Facility City State ZIP Site status
DaVita Philadelphia PMC Dialysis Philadelphia Pennsylvania 19104
DaVita University City Dialysis Philadelphia Pennsylvania 19104
Buttonwood DaVita Dialysis 449 N Broad St, Philadelphia, PA 19123 Pennsylvania 19123
Vanderbilt Dialysis Clinic Nashville Tennessee 37204
Dialysis Clinic, Inc. Nashville Tennessee 37208
Vanderbilt Dialysis Clinic East Nashville Tennessee 37214

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05735743, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced Sep 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05735743 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →